Vanguard Group Inc

13F Holdings History for IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA)

Symbol: IOVA on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 25.1M shares
Security Ownership: 7.5%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in IOVANCE BIOTHERAPEUTICS, INC. Common Stock (IOVA)

2025-07-29 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 25.1M shares of IOVANCE BIOTHERAPEUTICS, INC. Common Stock (IOVA). This represents 7.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	7.5%		$44.9M	25.1M			$1.79	13G/A	6/30/2025	29 Jul 2025 13:46:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	0%	$43.1M	25.1M	-2,701,306	-9.72%	$1.72	Q2 2025
3/31/2025	0%	+0%	$92.5M	27.8M	+243,438		$3.33	Q1 2025
12/31/2024	0%	+0%	$204M	27.5M	+220,373	+0.81%	$7.40	Q4 2024
9/30/2024	0%	+0%	$256M	27.3M	+1,363,323	+5.25%	$9.39	Q3 2024
6/30/2024	0%	+0%	$208M	26M	+1,035,344	+4.16%	$8.02	Q2 2024
3/31/2024	0.01%	+0%	$369M	24.9M	+2,102,480	+9.22%	$14.82	Q1 2024
12/31/2023	0%	+0%	$185M	22.8M	+669,350	+3.02%	$8.13	Q4 2023
9/30/2023	0%	+0%	$101M	22.1M	+1,748,082	+8.57%	$4.55	Q3 2023
6/30/2023	0%	+0%	$144M	20.4M	+6,855,259	+50.6%	$7.04	Q2 2023
3/31/2023	0%	0%	$82.7M	13.5M	-922,953	-6.38%	$6.11	Q1 2023
12/31/2022	0%	+0%	$92.4M	14.5M	+209,328	+1.47%	$6.39	Q4 2022
9/30/2022	0%	+0%	$137M	14.3M	+890,727	+6.67%	$9.58	Q3 2022
6/30/2022	0%	+0%	$148M	13.4M	+1,021,374	+8.28%	$11.04	Q2 2022
3/31/2022	0%	+0%	$205M	12.3M	+143,866	+1.18%	$16.65	Q1 2022
12/31/2021	0.01%	+0%	$233M	12.2M	+268,798	+2.25%	$19.09	Q4 2021
9/30/2021	0.01%	0%	$294M	11.9M	-307,422	-2.51%	$24.66	Q3 2021
6/30/2021	0.01%	+0%	$318M	12.2M	+182,924	+1.52%	$26.02	Q2 2021
3/31/2021	0.01%	+0%	$382M	12.1M	+188,105	+1.59%	$31.66	Q1 2021
12/31/2020	0.02%	+0%	$551M	11.9M	+86,855	+0.74%	$46.40	Q4 2020
9/30/2020	0.01%	0%	$388M	11.8M	-449,943	-3.68%	$32.92	Q3 2020
6/30/2020	0.01%	+0%	$336M	12.2M	+1,099,259	+9.88%	$27.45	Q2 2020
3/31/2020	0.01%	+0%	$333M	11.1M	+276,082	+2.54%	$29.94	Q1 2020
12/31/2019	0.01%	+0%	$300M	10.9M	+324,949	+3.09%	$27.68	Q4 2019
9/30/2019	0.01%	+0%	$192M	10.5M	+2,036,339	+24%	$18.20	Q3 2019
6/30/2019	0.01%	+0%	$208M	8.49M	+2,688,963	+46.3%	$24.52	Q2 2019
3/31/2019	0%	+0%	$55.2M	5.8M	+23,809	+0.41%	$9.51	Q1 2019
12/31/2018	0%	+0%	$51.1M	5.78M	+1,730,287	+42.7%	$8.85	Q4 2018
9/30/2018	0%	+0%	$45.6M	4.05M	+302,649	+8.08%	$11.25	Q3 2018
6/30/2018	0%	+0%	$48M	3.75M	+470,277	+14.4%	$12.80	Q2 2018
3/31/2018	0%	+0%	$55.4M	3.28M	+523,633	+19%	$16.90	Q1 2018
12/31/2017	0%	+0%	$22M	2.75M	+245,384	+9.79%	$8.00	Q4 2017
9/30/2017	0%	+0%	$19.4M	2.51M	+314,615	+14.4%	$7.75	Q3 2017
6/30/2017	0%	+0%	$16.1M	2.19M	+2,192,224	NEW	$7.35	Q2 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.